Alliancebernstein L.P. Harmony Biosciences Holdings, Inc. Transaction History
Alliancebernstein L.P.
- $280 Billion
- Q4 2024
A detailed history of Alliancebernstein L.P. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 123,050 shares of HRMY stock, worth $4.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123,050
Previous 123,050
-0.0%
Holding current value
$4.03 Million
Previous $4.92 Million
13.86%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$217 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$191 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$155 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$74.6 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$51.7 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.94B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...